These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21115928)

  • 41. Prognostic significance of common preoperative laboratory variables in clear cell renal cell carcinoma.
    Lee SE; Byun SS; Han JH; Han BK; Hong SK
    BJU Int; 2006 Dec; 98(6):1228-32. PubMed ID: 17034508
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney.
    Aydin H; Chen L; Cheng L; Vaziri S; He H; Ganapathi R; Delahunt B; Magi-Galluzzi C; Zhou M
    Am J Surg Pathol; 2010 Nov; 34(11):1608-21. PubMed ID: 20924276
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A specific gene expression signature characterizes metastatic potential in clear cell renal cell carcinoma.
    Sanjmyatav J; Steiner T; Wunderlich H; Diegmann J; Gajda M; Junker K
    J Urol; 2011 Jul; 186(1):289-94. PubMed ID: 21600596
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic factors for renal cell carcinoma with tumor thrombus extension.
    Klatte T; Pantuck AJ; Riggs SB; Kleid MD; Shuch B; Zomorodian N; Kabbinavar FF; Belldegrun AS
    J Urol; 2007 Oct; 178(4 Pt 1):1189-95; discussion 1195. PubMed ID: 17698087
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Venous tumor invasion by renal cell carcinoma. Surgical technique, complications and survival rate].
    Gschwend J; Maier S; Flohr P; de Petriconi R; Hautmann RE
    Urologe A; 1994 Sep; 33(5):440-6. PubMed ID: 7974934
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cytogenetic alterations in renal tumors: a study of 38 Southeast Asian patients.
    Lau LC; Tan PH; Chong TW; Foo KT; Yip S
    Cancer Genet Cytogenet; 2007 May; 175(1):1-7. PubMed ID: 17498551
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma: Long-term survival data of 216 patients.
    Becker F; Siemer S; Humke U; Hack M; Ziegler M; Stöckle M
    Eur Urol; 2006 Feb; 49(2):308-13. PubMed ID: 16359779
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Loss of chromosomes in clear cell renal cell carcinoma and in corresponding renal parenchyma.
    Feil G; Leipoldt M; Nelde HJ; Wunderer A; Wechsel HW; Kaiser P; Bichler KH
    Anticancer Res; 1999; 19(2C):1477-82. PubMed ID: 10365127
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma.
    Blute ML; Itano NB; Cheville JC; Weaver AL; Lohse CM; Zincke H
    J Urol; 2003 Apr; 169(4):1276-81. PubMed ID: 12629342
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cytogenetic and molecular tumor profiling for type 1 and type 2 papillary renal cell carcinoma.
    Klatte T; Pantuck AJ; Said JW; Seligson DB; Rao NP; LaRochelle JC; Shuch B; Zisman A; Kabbinavar FF; Belldegrun AS
    Clin Cancer Res; 2009 Feb; 15(4):1162-9. PubMed ID: 19228721
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cytogenetic analysis of three primary Bellini duct carcinomas.
    Gregori-Romero MA; Morell-Quadreny L; Llombart-Bosch A
    Genes Chromosomes Cancer; 1996 Mar; 15(3):170-2. PubMed ID: 8721681
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reassessment of renal cell carcinoma lymph node staging: analysis of patterns of progression.
    Kwon T; Song C; Hong JH; Kim CS; Ahn H
    Urology; 2011 Feb; 77(2):373-8. PubMed ID: 20817274
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The therapeutic value of adrenalectomy in case of solitary metastatic spread originating from primary renal cell cancer.
    Kuczyk M; Wegener G; Jonas U
    Eur Urol; 2005 Aug; 48(2):252-7. PubMed ID: 15936136
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic factors for renal cell carcinoma with bone metastasis: who are the long-term survivors?
    Kume H; Kakutani S; Yamada Y; Shinohara M; Tominaga T; Suzuki M; Fujimura T; Fukuhara H; Enomoto Y; Nishimatsu H; Homma Y
    J Urol; 2011 May; 185(5):1611-4. PubMed ID: 21419440
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cytologic and cytogenetic diagnosis of pediatric renal cell carcinoma associated with t(X;17).
    Barroca H; Correia C; Castedo S
    Acta Cytol; 2008; 52(3):384-6. PubMed ID: 18540314
    [No Abstract]   [Full Text] [Related]  

  • 56. Tubulocystic carcinoma of the kidney with poorly differentiated foci: a series of 3 cases with fluorescence in situ hybridization analysis.
    Al-Hussain TO; Cheng L; Zhang S; Epstein JI
    Hum Pathol; 2013 Jul; 44(7):1406-11. PubMed ID: 23427871
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Cytogenetics profiles of renal carcinoma].
    Dugay F; Dagher J; Verhoest G; Henry C; Jaillard S; Arlot-Bonnemains Y; Bensalah K; Vigneau C; Rioux-Leclercq N; Belaud-Rotureau MA
    Morphologie; 2014 Mar; 98(320):1-7. PubMed ID: 24656859
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cell cycle progression score predicts metastatic progression of clear cell renal cell carcinoma after resection.
    Askeland EJ; Chehval VA; Askeland RW; Fosso PG; Sangale Z; Xu N; Rajamani S; Stone S; Brown JA
    Cancer Biomark; 2015; 15(6):861-7. PubMed ID: 26406412
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic implications of cytogenetic findings in kidney cancer.
    Elfving P; Mandahl N; Lundgren R; Limon J; Bak-Jensen E; Fernö M; Olsson H; Mitelman F
    Br J Urol; 1997 Nov; 80(5):698-706. PubMed ID: 9393289
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic factors in renal cell carcinoma.
    Ljungberg B
    Urologe A; 2004 Sep; 43 Suppl 3():S119-20. PubMed ID: 15179550
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.